IN THE NEWS

MSNBC: Why the FDA is right about Zyn

This is the FDA doing its job exactly as required by the 2009 Tobacco Control Act.

FDA: FDA Authorizes Marketing of 20 ZYN Nicotine Pouch Products after Extensive Scientific Review

To receive marketing authorizations, the FDA must have sufficient evidence that the new products offer greater benefits to population health than risks,” said Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products. 

BROOKINGS: Harm reduction and its role in improving health outcomes in an era of fentanyl

Reducing harm is a core element of public health and is intertwined with another fundamental tenet of public health—health promotion. 

ACLU: Failed War on Drugs Policies Won't Stop the Overdose Crisis, But Harm Reduction Can Save Lives

Research shows extensive benefits from syringe exchange and other harm reduction programs. But misguided efforts to ban common sense care continue.

NEWS MEDICAL: Tackling the Dual Epidemics of HIV and Addiction

Case studies from countries such as Portugal and Australia demonstrate the success of holistic, community-based approaches, serving as examples of the benefits of policy implementations aimed at mitigating stigma and discrimination at the national level.

The Scientific Foundation for Tobacco Harm Reduction

"Compiled by leading experts in the field, this report makes the case for harm reduction strategies to protect smokers. It demonstrates that smokers smoke predominantly for nicotine, that nicotine itself is not especially hazardous, and that if nicotine could be provided in a form that is acceptable and effective as a cigarette substitute, millions of lives could be saved." – Royal College of Physicians